Women who receive higher amounts of daily magnesium, either from their diet or supplements, have a modestly lower risk for hypertension, according to a report in the December issue of the American Journal of Cardiology.
Women who receive higher amounts of daily magnesium, either from their diet or supplements, have a modestly lower risk for hypertension, according to a report in the December issue of the American Journal of Cardiology.
Yiqing Song, MD, of Brigham and Women's Hospital and Harvard Medical School in Boston, and colleagues examined the relationship between magnesium intake and hypertension using data from 28,349 professional women, aged 45 or older, enrolled in the Women's Health Study. Overall, 8,544 developed hypertension during a median follow-up of 9.8 years.
The researchers found that hypertension risk was inversely related to magnesium intake, with a high daily median intake of 434 mg cutting hypertension risk by 13% compared with those consuming the lowest amount of magnesium. After multivariate adjustments, the relationship was more modest-about a 7% reduction in the highest intake group compared with the lowest-but still significant.
Song Y, Sesso HD, Manson J, et al. Dietary magnesium intake and risk of incident hypertension among middle-aged and older US women in a 10-year follow-up study. Am J Cardiol. 2006;98:1616-1621.
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More